Global Biodegradable Coronary Stents Market Growth 2025-2031--LP INFORMATION, INC.

Global Biodegradable Coronary Stents Market Growth 2025-2031

Product Code: 1540253

Industry: Medical Devices & Consumables

Published: May 13,2025

Pages: 130

Delivery Time: 2-3 business days

Global Biodegradable Coronary Stents Market Growth 2025-2031

Product Code: 1540253

Industry: Medical Devices & Consumables

Published: May 13,2025

Pages: 130

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Biodegradable Coronary Stents market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Biodegradable Coronary Stents, also known as bioresorbable stents or scaffolds, are a type of stent used in the treatment of coronary artery disease. Unlike traditional metal stents, which remain permanently in the body, biodegradable stents are designed to provide temporary support to the artery and then gradually dissolve or degrade over time. This process typically takes 2 to 3 years, depending on the material used.

United States market for Biodegradable Coronary Stents is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Biodegradable Coronary Stents is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Biodegradable Coronary Stents is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Biodegradable Coronary Stents players cover Q3 Medical, Shandong Huaan Biotechnology, Boston Scientific, Terumo, Abbott, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Biodegradable Coronary Stents Industry Forecast” looks at past sales and reviews total world Biodegradable Coronary Stents sales in 2024, providing a comprehensive analysis by region and market sector of projected Biodegradable Coronary Stents sales for 2025 through 2031. With Biodegradable Coronary Stents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biodegradable Coronary Stents industry.

This Insight Report provides a comprehensive analysis of the global Biodegradable Coronary Stents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biodegradable Coronary Stents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biodegradable Coronary Stents market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biodegradable Coronary Stents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biodegradable Coronary Stents.

This report presents a comprehensive overview, market shares, and growth opportunities of Biodegradable Coronary Stents market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Polylactic Acid (PLA)

    Magnesium Alloys

    Others

Segmentation by Application:

    Percutaneous Coronary Intervention (PCI)

    Drug-Eluting

    Post-Procedure Management

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Q3 Medical

    Shandong Huaan Biotechnology

    Boston Scientific

    Terumo

    Abbott

3M

    Arterius

    Elixir Medical

    Kyoto Medical

    Biotronik

SMT

    Amaranth Medical

    AMG International

    Cardionovum

    Lepu Medical

    REVA Medical (1)

    Wego Healthcare

    SINOMED

Key Questions Addressed in this Report

What is the 10-year outlook for the global Biodegradable Coronary Stents market?

What factors are driving Biodegradable Coronary Stents market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Biodegradable Coronary Stents market opportunities vary by end market size?

How does Biodegradable Coronary Stents break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Biodegradable Coronary Stents Annual Sales 2020-2031
        2.1.2 World Current & Future Analysis for Biodegradable Coronary Stents by Geographic Region, 2020, 2024 & 2031
        2.1.3 World Current & Future Analysis for Biodegradable Coronary Stents by Country/Region, 2020, 2024 & 2031
    2.2 Biodegradable Coronary Stents Segment by Type
        2.2.1 Polylactic Acid (PLA)
        2.2.2 Magnesium Alloys
        2.2.3 Others
    2.3 Biodegradable Coronary Stents Sales by Type
        2.3.1 Global Biodegradable Coronary Stents Sales Market Share by Type (2020-2025)
        2.3.2 Global Biodegradable Coronary Stents Revenue and Market Share by Type (2020-2025)
        2.3.3 Global Biodegradable Coronary Stents Sale Price by Type (2020-2025)
    2.4 Biodegradable Coronary Stents Segment by Application
        2.4.1 Percutaneous Coronary Intervention (PCI)
        2.4.2 Drug-Eluting
        2.4.3 Post-Procedure Management
    2.5 Biodegradable Coronary Stents Sales by Application
        2.5.1 Global Biodegradable Coronary Stents Sale Market Share by Application (2020-2025)
        2.5.2 Global Biodegradable Coronary Stents Revenue and Market Share by Application (2020-2025)
        2.5.3 Global Biodegradable Coronary Stents Sale Price by Application (2020-2025)

3 Global by Company
    3.1 Global Biodegradable Coronary Stents Breakdown Data by Company
        3.1.1 Global Biodegradable Coronary Stents Annual Sales by Company (2020-2025)
        3.1.2 Global Biodegradable Coronary Stents Sales Market Share by Company (2020-2025)
    3.2 Global Biodegradable Coronary Stents Annual Revenue by Company (2020-2025)
        3.2.1 Global Biodegradable Coronary Stents Revenue by Company (2020-2025)
        3.2.2 Global Biodegradable Coronary Stents Revenue Market Share by Company (2020-2025)
    3.3 Global Biodegradable Coronary Stents Sale Price by Company
    3.4 Key Manufacturers Biodegradable Coronary Stents Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Biodegradable Coronary Stents Product Location Distribution
        3.4.2 Players Biodegradable Coronary Stents Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Biodegradable Coronary Stents by Geographic Region
    4.1 World Historic Biodegradable Coronary Stents Market Size by Geographic Region (2020-2025)
        4.1.1 Global Biodegradable Coronary Stents Annual Sales by Geographic Region (2020-2025)
        4.1.2 Global Biodegradable Coronary Stents Annual Revenue by Geographic Region (2020-2025)
    4.2 World Historic Biodegradable Coronary Stents Market Size by Country/Region (2020-2025)
        4.2.1 Global Biodegradable Coronary Stents Annual Sales by Country/Region (2020-2025)
        4.2.2 Global Biodegradable Coronary Stents Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Biodegradable Coronary Stents Sales Growth
    4.4 APAC Biodegradable Coronary Stents Sales Growth
    4.5 Europe Biodegradable Coronary Stents Sales Growth
    4.6 Middle East & Africa Biodegradable Coronary Stents Sales Growth

5 Americas
    5.1 Americas Biodegradable Coronary Stents Sales by Country
        5.1.1 Americas Biodegradable Coronary Stents Sales by Country (2020-2025)
        5.1.2 Americas Biodegradable Coronary Stents Revenue by Country (2020-2025)
    5.2 Americas Biodegradable Coronary Stents Sales by Type (2020-2025)
    5.3 Americas Biodegradable Coronary Stents Sales by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Biodegradable Coronary Stents Sales by Region
        6.1.1 APAC Biodegradable Coronary Stents Sales by Region (2020-2025)
        6.1.2 APAC Biodegradable Coronary Stents Revenue by Region (2020-2025)
    6.2 APAC Biodegradable Coronary Stents Sales by Type (2020-2025)
    6.3 APAC Biodegradable Coronary Stents Sales by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Biodegradable Coronary Stents by Country
        7.1.1 Europe Biodegradable Coronary Stents Sales by Country (2020-2025)
        7.1.2 Europe Biodegradable Coronary Stents Revenue by Country (2020-2025)
    7.2 Europe Biodegradable Coronary Stents Sales by Type (2020-2025)
    7.3 Europe Biodegradable Coronary Stents Sales by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Biodegradable Coronary Stents by Country
        8.1.1 Middle East & Africa Biodegradable Coronary Stents Sales by Country (2020-2025)
        8.1.2 Middle East & Africa Biodegradable Coronary Stents Revenue by Country (2020-2025)
    8.2 Middle East & Africa Biodegradable Coronary Stents Sales by Type (2020-2025)
    8.3 Middle East & Africa Biodegradable Coronary Stents Sales by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Biodegradable Coronary Stents
    10.3 Manufacturing Process Analysis of Biodegradable Coronary Stents
    10.4 Industry Chain Structure of Biodegradable Coronary Stents

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Biodegradable Coronary Stents Distributors
    11.3 Biodegradable Coronary Stents Customer

12 World Forecast Review for Biodegradable Coronary Stents by Geographic Region
    12.1 Global Biodegradable Coronary Stents Market Size Forecast by Region
        12.1.1 Global Biodegradable Coronary Stents Forecast by Region (2026-2031)
        12.1.2 Global Biodegradable Coronary Stents Annual Revenue Forecast by Region (2026-2031)
    12.2 Americas Forecast by Country (2026-2031)
    12.3 APAC Forecast by Region (2026-2031)
    12.4 Europe Forecast by Country (2026-2031)
    12.5 Middle East & Africa Forecast by Country (2026-2031)
    12.6 Global Biodegradable Coronary Stents Forecast by Type (2026-2031)
    12.7 Global Biodegradable Coronary Stents Forecast by Application (2026-2031)

13 Key Players Analysis
    13.1 Q3 Medical
        13.1.1 Q3 Medical Company Information
        13.1.2 Q3 Medical Biodegradable Coronary Stents Product Portfolios and Specifications
        13.1.3 Q3 Medical Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2025)
        13.1.4 Q3 Medical Main Business Overview
        13.1.5 Q3 Medical Latest Developments
    13.2 Shandong Huaan Biotechnology
        13.2.1 Shandong Huaan Biotechnology Company Information
        13.2.2 Shandong Huaan Biotechnology Biodegradable Coronary Stents Product Portfolios and Specifications
        13.2.3 Shandong Huaan Biotechnology Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2025)
        13.2.4 Shandong Huaan Biotechnology Main Business Overview
        13.2.5 Shandong Huaan Biotechnology Latest Developments
    13.3 Boston Scientific
        13.3.1 Boston Scientific Company Information
        13.3.2 Boston Scientific Biodegradable Coronary Stents Product Portfolios and Specifications
        13.3.3 Boston Scientific Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2025)
        13.3.4 Boston Scientific Main Business Overview
        13.3.5 Boston Scientific Latest Developments
    13.4 Terumo
        13.4.1 Terumo Company Information
        13.4.2 Terumo Biodegradable Coronary Stents Product Portfolios and Specifications
        13.4.3 Terumo Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2025)
        13.4.4 Terumo Main Business Overview
        13.4.5 Terumo Latest Developments
    13.5 Abbott
        13.5.1 Abbott Company Information
        13.5.2 Abbott Biodegradable Coronary Stents Product Portfolios and Specifications
        13.5.3 Abbott Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2025)
        13.5.4 Abbott Main Business Overview
        13.5.5 Abbott Latest Developments
    13.6 3M
        13.6.1 3M Company Information
        13.6.2 3M Biodegradable Coronary Stents Product Portfolios and Specifications
        13.6.3 3M Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2025)
        13.6.4 3M Main Business Overview
        13.6.5 3M Latest Developments
    13.7 Arterius
        13.7.1 Arterius Company Information
        13.7.2 Arterius Biodegradable Coronary Stents Product Portfolios and Specifications
        13.7.3 Arterius Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2025)
        13.7.4 Arterius Main Business Overview
        13.7.5 Arterius Latest Developments
    13.8 Elixir Medical
        13.8.1 Elixir Medical Company Information
        13.8.2 Elixir Medical Biodegradable Coronary Stents Product Portfolios and Specifications
        13.8.3 Elixir Medical Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2025)
        13.8.4 Elixir Medical Main Business Overview
        13.8.5 Elixir Medical Latest Developments
    13.9 Kyoto Medical
        13.9.1 Kyoto Medical Company Information
        13.9.2 Kyoto Medical Biodegradable Coronary Stents Product Portfolios and Specifications
        13.9.3 Kyoto Medical Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2025)
        13.9.4 Kyoto Medical Main Business Overview
        13.9.5 Kyoto Medical Latest Developments
    13.10 Biotronik
        13.10.1 Biotronik Company Information
        13.10.2 Biotronik Biodegradable Coronary Stents Product Portfolios and Specifications
        13.10.3 Biotronik Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2025)
        13.10.4 Biotronik Main Business Overview
        13.10.5 Biotronik Latest Developments
    13.11 SMT
        13.11.1 SMT Company Information
        13.11.2 SMT Biodegradable Coronary Stents Product Portfolios and Specifications
        13.11.3 SMT Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2025)
        13.11.4 SMT Main Business Overview
        13.11.5 SMT Latest Developments
    13.12 Amaranth Medical
        13.12.1 Amaranth Medical Company Information
        13.12.2 Amaranth Medical Biodegradable Coronary Stents Product Portfolios and Specifications
        13.12.3 Amaranth Medical Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2025)
        13.12.4 Amaranth Medical Main Business Overview
        13.12.5 Amaranth Medical Latest Developments
    13.13 AMG International
        13.13.1 AMG International Company Information
        13.13.2 AMG International Biodegradable Coronary Stents Product Portfolios and Specifications
        13.13.3 AMG International Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2025)
        13.13.4 AMG International Main Business Overview
        13.13.5 AMG International Latest Developments
    13.14 Cardionovum
        13.14.1 Cardionovum Company Information
        13.14.2 Cardionovum Biodegradable Coronary Stents Product Portfolios and Specifications
        13.14.3 Cardionovum Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2025)
        13.14.4 Cardionovum Main Business Overview
        13.14.5 Cardionovum Latest Developments
    13.15 Lepu Medical
        13.15.1 Lepu Medical Company Information
        13.15.2 Lepu Medical Biodegradable Coronary Stents Product Portfolios and Specifications
        13.15.3 Lepu Medical Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2025)
        13.15.4 Lepu Medical Main Business Overview
        13.15.5 Lepu Medical Latest Developments
    13.16 REVA Medical (1)
        13.16.1 REVA Medical (1) Company Information
        13.16.2 REVA Medical (1) Biodegradable Coronary Stents Product Portfolios and Specifications
        13.16.3 REVA Medical (1) Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2025)
        13.16.4 REVA Medical (1) Main Business Overview
        13.16.5 REVA Medical (1) Latest Developments
    13.17 Wego Healthcare
        13.17.1 Wego Healthcare Company Information
        13.17.2 Wego Healthcare Biodegradable Coronary Stents Product Portfolios and Specifications
        13.17.3 Wego Healthcare Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2025)
        13.17.4 Wego Healthcare Main Business Overview
        13.17.5 Wego Healthcare Latest Developments
    13.18 SINOMED
        13.18.1 SINOMED Company Information
        13.18.2 SINOMED Biodegradable Coronary Stents Product Portfolios and Specifications
        13.18.3 SINOMED Biodegradable Coronary Stents Sales, Revenue, Price and Gross Margin (2020-2025)
        13.18.4 SINOMED Main Business Overview
        13.18.5 SINOMED Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Biodegradable Coronary Stents Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. Biodegradable Coronary Stents Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Polylactic Acid (PLA)
 Table 4. Major Players of Magnesium Alloys
 Table 5. Major Players of Others
 Table 6. Global Biodegradable Coronary Stents Sales by Type (2020-2025) & (Units)
 Table 7. Global Biodegradable Coronary Stents Sales Market Share by Type (2020-2025)
 Table 8. Global Biodegradable Coronary Stents Revenue by Type (2020-2025) & ($ million)
 Table 9. Global Biodegradable Coronary Stents Revenue Market Share by Type (2020-2025)
 Table 10. Global Biodegradable Coronary Stents Sale Price by Type (2020-2025) & (US$/Unit)
 Table 11. Global Biodegradable Coronary Stents Sale by Application (2020-2025) & (Units)
 Table 12. Global Biodegradable Coronary Stents Sale Market Share by Application (2020-2025)
 Table 13. Global Biodegradable Coronary Stents Revenue by Application (2020-2025) & ($ million)
 Table 14. Global Biodegradable Coronary Stents Revenue Market Share by Application (2020-2025)
 Table 15. Global Biodegradable Coronary Stents Sale Price by Application (2020-2025) & (US$/Unit)
 Table 16. Global Biodegradable Coronary Stents Sales by Company (2020-2025) & (Units)
 Table 17. Global Biodegradable Coronary Stents Sales Market Share by Company (2020-2025)
 Table 18. Global Biodegradable Coronary Stents Revenue by Company (2020-2025) & ($ millions)
 Table 19. Global Biodegradable Coronary Stents Revenue Market Share by Company (2020-2025)
 Table 20. Global Biodegradable Coronary Stents Sale Price by Company (2020-2025) & (US$/Unit)
 Table 21. Key Manufacturers Biodegradable Coronary Stents Producing Area Distribution and Sales Area
 Table 22. Players Biodegradable Coronary Stents Products Offered
 Table 23. Biodegradable Coronary Stents Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 24. New Products and Potential Entrants
 Table 25. Market M&A Activity & Strategy
 Table 26. Global Biodegradable Coronary Stents Sales by Geographic Region (2020-2025) & (Units)
 Table 27. Global Biodegradable Coronary Stents Sales Market Share Geographic Region (2020-2025)
 Table 28. Global Biodegradable Coronary Stents Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 29. Global Biodegradable Coronary Stents Revenue Market Share by Geographic Region (2020-2025)
 Table 30. Global Biodegradable Coronary Stents Sales by Country/Region (2020-2025) & (Units)
 Table 31. Global Biodegradable Coronary Stents Sales Market Share by Country/Region (2020-2025)
 Table 32. Global Biodegradable Coronary Stents Revenue by Country/Region (2020-2025) & ($ millions)
 Table 33. Global Biodegradable Coronary Stents Revenue Market Share by Country/Region (2020-2025)
 Table 34. Americas Biodegradable Coronary Stents Sales by Country (2020-2025) & (Units)
 Table 35. Americas Biodegradable Coronary Stents Sales Market Share by Country (2020-2025)
 Table 36. Americas Biodegradable Coronary Stents Revenue by Country (2020-2025) & ($ millions)
 Table 37. Americas Biodegradable Coronary Stents Sales by Type (2020-2025) & (Units)
 Table 38. Americas Biodegradable Coronary Stents Sales by Application (2020-2025) & (Units)
 Table 39. APAC Biodegradable Coronary Stents Sales by Region (2020-2025) & (Units)
 Table 40. APAC Biodegradable Coronary Stents Sales Market Share by Region (2020-2025)
 Table 41. APAC Biodegradable Coronary Stents Revenue by Region (2020-2025) & ($ millions)
 Table 42. APAC Biodegradable Coronary Stents Sales by Type (2020-2025) & (Units)
 Table 43. APAC Biodegradable Coronary Stents Sales by Application (2020-2025) & (Units)
 Table 44. Europe Biodegradable Coronary Stents Sales by Country (2020-2025) & (Units)
 Table 45. Europe Biodegradable Coronary Stents Revenue by Country (2020-2025) & ($ millions)
 Table 46. Europe Biodegradable Coronary Stents Sales by Type (2020-2025) & (Units)
 Table 47. Europe Biodegradable Coronary Stents Sales by Application (2020-2025) & (Units)
 Table 48. Middle East & Africa Biodegradable Coronary Stents Sales by Country (2020-2025) & (Units)
 Table 49. Middle East & Africa Biodegradable Coronary Stents Revenue Market Share by Country (2020-2025)
 Table 50. Middle East & Africa Biodegradable Coronary Stents Sales by Type (2020-2025) & (Units)
 Table 51. Middle East & Africa Biodegradable Coronary Stents Sales by Application (2020-2025) & (Units)
 Table 52. Key Market Drivers & Growth Opportunities of Biodegradable Coronary Stents
 Table 53. Key Market Challenges & Risks of Biodegradable Coronary Stents
 Table 54. Key Industry Trends of Biodegradable Coronary Stents
 Table 55. Biodegradable Coronary Stents Raw Material
 Table 56. Key Suppliers of Raw Materials
 Table 57. Biodegradable Coronary Stents Distributors List
 Table 58. Biodegradable Coronary Stents Customer List
 Table 59. Global Biodegradable Coronary Stents Sales Forecast by Region (2026-2031) & (Units)
 Table 60. Global Biodegradable Coronary Stents Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 61. Americas Biodegradable Coronary Stents Sales Forecast by Country (2026-2031) & (Units)
 Table 62. Americas Biodegradable Coronary Stents Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 63. APAC Biodegradable Coronary Stents Sales Forecast by Region (2026-2031) & (Units)
 Table 64. APAC Biodegradable Coronary Stents Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 65. Europe Biodegradable Coronary Stents Sales Forecast by Country (2026-2031) & (Units)
 Table 66. Europe Biodegradable Coronary Stents Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 67. Middle East & Africa Biodegradable Coronary Stents Sales Forecast by Country (2026-2031) & (Units)
 Table 68. Middle East & Africa Biodegradable Coronary Stents Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 69. Global Biodegradable Coronary Stents Sales Forecast by Type (2026-2031) & (Units)
 Table 70. Global Biodegradable Coronary Stents Revenue Forecast by Type (2026-2031) & ($ millions)
 Table 71. Global Biodegradable Coronary Stents Sales Forecast by Application (2026-2031) & (Units)
 Table 72. Global Biodegradable Coronary Stents Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 73. Q3 Medical Basic Information, Biodegradable Coronary Stents Manufacturing Base, Sales Area and Its Competitors
 Table 74. Q3 Medical Biodegradable Coronary Stents Product Portfolios and Specifications
 Table 75. Q3 Medical Biodegradable Coronary Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 76. Q3 Medical Main Business
 Table 77. Q3 Medical Latest Developments
 Table 78. Shandong Huaan Biotechnology Basic Information, Biodegradable Coronary Stents Manufacturing Base, Sales Area and Its Competitors
 Table 79. Shandong Huaan Biotechnology Biodegradable Coronary Stents Product Portfolios and Specifications
 Table 80. Shandong Huaan Biotechnology Biodegradable Coronary Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Shandong Huaan Biotechnology Main Business
 Table 82. Shandong Huaan Biotechnology Latest Developments
 Table 83. Boston Scientific Basic Information, Biodegradable Coronary Stents Manufacturing Base, Sales Area and Its Competitors
 Table 84. Boston Scientific Biodegradable Coronary Stents Product Portfolios and Specifications
 Table 85. Boston Scientific Biodegradable Coronary Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 86. Boston Scientific Main Business
 Table 87. Boston Scientific Latest Developments
 Table 88. Terumo Basic Information, Biodegradable Coronary Stents Manufacturing Base, Sales Area and Its Competitors
 Table 89. Terumo Biodegradable Coronary Stents Product Portfolios and Specifications
 Table 90. Terumo Biodegradable Coronary Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 91. Terumo Main Business
 Table 92. Terumo Latest Developments
 Table 93. Abbott Basic Information, Biodegradable Coronary Stents Manufacturing Base, Sales Area and Its Competitors
 Table 94. Abbott Biodegradable Coronary Stents Product Portfolios and Specifications
 Table 95. Abbott Biodegradable Coronary Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 96. Abbott Main Business
 Table 97. Abbott Latest Developments
 Table 98. 3M Basic Information, Biodegradable Coronary Stents Manufacturing Base, Sales Area and Its Competitors
 Table 99. 3M Biodegradable Coronary Stents Product Portfolios and Specifications
 Table 100. 3M Biodegradable Coronary Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 101. 3M Main Business
 Table 102. 3M Latest Developments
 Table 103. Arterius Basic Information, Biodegradable Coronary Stents Manufacturing Base, Sales Area and Its Competitors
 Table 104. Arterius Biodegradable Coronary Stents Product Portfolios and Specifications
 Table 105. Arterius Biodegradable Coronary Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 106. Arterius Main Business
 Table 107. Arterius Latest Developments
 Table 108. Elixir Medical Basic Information, Biodegradable Coronary Stents Manufacturing Base, Sales Area and Its Competitors
 Table 109. Elixir Medical Biodegradable Coronary Stents Product Portfolios and Specifications
 Table 110. Elixir Medical Biodegradable Coronary Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 111. Elixir Medical Main Business
 Table 112. Elixir Medical Latest Developments
 Table 113. Kyoto Medical Basic Information, Biodegradable Coronary Stents Manufacturing Base, Sales Area and Its Competitors
 Table 114. Kyoto Medical Biodegradable Coronary Stents Product Portfolios and Specifications
 Table 115. Kyoto Medical Biodegradable Coronary Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 116. Kyoto Medical Main Business
 Table 117. Kyoto Medical Latest Developments
 Table 118. Biotronik Basic Information, Biodegradable Coronary Stents Manufacturing Base, Sales Area and Its Competitors
 Table 119. Biotronik Biodegradable Coronary Stents Product Portfolios and Specifications
 Table 120. Biotronik Biodegradable Coronary Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 121. Biotronik Main Business
 Table 122. Biotronik Latest Developments
 Table 123. SMT Basic Information, Biodegradable Coronary Stents Manufacturing Base, Sales Area and Its Competitors
 Table 124. SMT Biodegradable Coronary Stents Product Portfolios and Specifications
 Table 125. SMT Biodegradable Coronary Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 126. SMT Main Business
 Table 127. SMT Latest Developments
 Table 128. Amaranth Medical Basic Information, Biodegradable Coronary Stents Manufacturing Base, Sales Area and Its Competitors
 Table 129. Amaranth Medical Biodegradable Coronary Stents Product Portfolios and Specifications
 Table 130. Amaranth Medical Biodegradable Coronary Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 131. Amaranth Medical Main Business
 Table 132. Amaranth Medical Latest Developments
 Table 133. AMG International Basic Information, Biodegradable Coronary Stents Manufacturing Base, Sales Area and Its Competitors
 Table 134. AMG International Biodegradable Coronary Stents Product Portfolios and Specifications
 Table 135. AMG International Biodegradable Coronary Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 136. AMG International Main Business
 Table 137. AMG International Latest Developments
 Table 138. Cardionovum Basic Information, Biodegradable Coronary Stents Manufacturing Base, Sales Area and Its Competitors
 Table 139. Cardionovum Biodegradable Coronary Stents Product Portfolios and Specifications
 Table 140. Cardionovum Biodegradable Coronary Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 141. Cardionovum Main Business
 Table 142. Cardionovum Latest Developments
 Table 143. Lepu Medical Basic Information, Biodegradable Coronary Stents Manufacturing Base, Sales Area and Its Competitors
 Table 144. Lepu Medical Biodegradable Coronary Stents Product Portfolios and Specifications
 Table 145. Lepu Medical Biodegradable Coronary Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 146. Lepu Medical Main Business
 Table 147. Lepu Medical Latest Developments
 Table 148. REVA Medical (1) Basic Information, Biodegradable Coronary Stents Manufacturing Base, Sales Area and Its Competitors
 Table 149. REVA Medical (1) Biodegradable Coronary Stents Product Portfolios and Specifications
 Table 150. REVA Medical (1) Biodegradable Coronary Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 151. REVA Medical (1) Main Business
 Table 152. REVA Medical (1) Latest Developments
 Table 153. Wego Healthcare Basic Information, Biodegradable Coronary Stents Manufacturing Base, Sales Area and Its Competitors
 Table 154. Wego Healthcare Biodegradable Coronary Stents Product Portfolios and Specifications
 Table 155. Wego Healthcare Biodegradable Coronary Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 156. Wego Healthcare Main Business
 Table 157. Wego Healthcare Latest Developments
 Table 158. SINOMED Basic Information, Biodegradable Coronary Stents Manufacturing Base, Sales Area and Its Competitors
 Table 159. SINOMED Biodegradable Coronary Stents Product Portfolios and Specifications
 Table 160. SINOMED Biodegradable Coronary Stents Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 161. SINOMED Main Business
 Table 162. SINOMED Latest Developments


List of Figures
 Figure 1. Picture of Biodegradable Coronary Stents
 Figure 2. Biodegradable Coronary Stents Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Biodegradable Coronary Stents Sales Growth Rate 2020-2031 (Units)
 Figure 7. Global Biodegradable Coronary Stents Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. Biodegradable Coronary Stents Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. Biodegradable Coronary Stents Sales Market Share by Country/Region (2024)
 Figure 10. Biodegradable Coronary Stents Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of Polylactic Acid (PLA)
 Figure 12. Product Picture of Magnesium Alloys
 Figure 13. Product Picture of Others
 Figure 14. Global Biodegradable Coronary Stents Sales Market Share by Type in 2025
 Figure 15. Global Biodegradable Coronary Stents Revenue Market Share by Type (2020-2025)
 Figure 16. Biodegradable Coronary Stents Consumed in Percutaneous Coronary Intervention (PCI)
 Figure 17. Global Biodegradable Coronary Stents Market: Percutaneous Coronary Intervention (PCI) (2020-2025) & (Units)
 Figure 18. Biodegradable Coronary Stents Consumed in Drug-Eluting
 Figure 19. Global Biodegradable Coronary Stents Market: Drug-Eluting (2020-2025) & (Units)
 Figure 20. Biodegradable Coronary Stents Consumed in Post-Procedure Management
 Figure 21. Global Biodegradable Coronary Stents Market: Post-Procedure Management (2020-2025) & (Units)
 Figure 22. Global Biodegradable Coronary Stents Sale Market Share by Application (2024)
 Figure 23. Global Biodegradable Coronary Stents Revenue Market Share by Application in 2025
 Figure 24. Biodegradable Coronary Stents Sales by Company in 2025 (Units)
 Figure 25. Global Biodegradable Coronary Stents Sales Market Share by Company in 2025
 Figure 26. Biodegradable Coronary Stents Revenue by Company in 2025 ($ millions)
 Figure 27. Global Biodegradable Coronary Stents Revenue Market Share by Company in 2025
 Figure 28. Global Biodegradable Coronary Stents Sales Market Share by Geographic Region (2020-2025)
 Figure 29. Global Biodegradable Coronary Stents Revenue Market Share by Geographic Region in 2025
 Figure 30. Americas Biodegradable Coronary Stents Sales 2020-2025 (Units)
 Figure 31. Americas Biodegradable Coronary Stents Revenue 2020-2025 ($ millions)
 Figure 32. APAC Biodegradable Coronary Stents Sales 2020-2025 (Units)
 Figure 33. APAC Biodegradable Coronary Stents Revenue 2020-2025 ($ millions)
 Figure 34. Europe Biodegradable Coronary Stents Sales 2020-2025 (Units)
 Figure 35. Europe Biodegradable Coronary Stents Revenue 2020-2025 ($ millions)
 Figure 36. Middle East & Africa Biodegradable Coronary Stents Sales 2020-2025 (Units)
 Figure 37. Middle East & Africa Biodegradable Coronary Stents Revenue 2020-2025 ($ millions)
 Figure 38. Americas Biodegradable Coronary Stents Sales Market Share by Country in 2025
 Figure 39. Americas Biodegradable Coronary Stents Revenue Market Share by Country (2020-2025)
 Figure 40. Americas Biodegradable Coronary Stents Sales Market Share by Type (2020-2025)
 Figure 41. Americas Biodegradable Coronary Stents Sales Market Share by Application (2020-2025)
 Figure 42. United States Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 43. Canada Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 44. Mexico Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 45. Brazil Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 46. APAC Biodegradable Coronary Stents Sales Market Share by Region in 2025
 Figure 47. APAC Biodegradable Coronary Stents Revenue Market Share by Region (2020-2025)
 Figure 48. APAC Biodegradable Coronary Stents Sales Market Share by Type (2020-2025)
 Figure 49. APAC Biodegradable Coronary Stents Sales Market Share by Application (2020-2025)
 Figure 50. China Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 51. Japan Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 52. South Korea Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 53. Southeast Asia Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 54. India Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 55. Australia Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 56. China Taiwan Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 57. Europe Biodegradable Coronary Stents Sales Market Share by Country in 2025
 Figure 58. Europe Biodegradable Coronary Stents Revenue Market Share by Country (2020-2025)
 Figure 59. Europe Biodegradable Coronary Stents Sales Market Share by Type (2020-2025)
 Figure 60. Europe Biodegradable Coronary Stents Sales Market Share by Application (2020-2025)
 Figure 61. Germany Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 62. France Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 63. UK Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 64. Italy Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 65. Russia Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 66. Middle East & Africa Biodegradable Coronary Stents Sales Market Share by Country (2020-2025)
 Figure 67. Middle East & Africa Biodegradable Coronary Stents Sales Market Share by Type (2020-2025)
 Figure 68. Middle East & Africa Biodegradable Coronary Stents Sales Market Share by Application (2020-2025)
 Figure 69. Egypt Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 70. South Africa Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 71. Israel Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 72. Turkey Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 73. GCC Countries Biodegradable Coronary Stents Revenue Growth 2020-2025 ($ millions)
 Figure 74. Manufacturing Cost Structure Analysis of Biodegradable Coronary Stents in 2025
 Figure 75. Manufacturing Process Analysis of Biodegradable Coronary Stents
 Figure 76. Industry Chain Structure of Biodegradable Coronary Stents
 Figure 77. Channels of Distribution
 Figure 78. Global Biodegradable Coronary Stents Sales Market Forecast by Region (2026-2031)
 Figure 79. Global Biodegradable Coronary Stents Revenue Market Share Forecast by Region (2026-2031)
 Figure 80. Global Biodegradable Coronary Stents Sales Market Share Forecast by Type (2026-2031)
 Figure 81. Global Biodegradable Coronary Stents Revenue Market Share Forecast by Type (2026-2031)
 Figure 82. Global Biodegradable Coronary Stents Sales Market Share Forecast by Application (2026-2031)
 Figure 83. Global Biodegradable Coronary Stents Revenue Market Share Forecast by Application (2026-2031)

Companies Mentioned

Q3 Medical

Shandong Huaan Biotechnology

Boston Scientific

Terumo

Abbott

Arterius

Elixir Medical

Kyoto Medical

Biotronik

SMT

Amaranth Medical

AMG International

Cardionovum

Lepu Medical

REVA Medical (1)

Wego Healthcare

SINOMED

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff